Alnylam Pharmaceuticals Inc (ALNY)
269.17
-11.79
(-4.20%)
USD |
NASDAQ |
Mar 26, 16:00
269.17
0.00 (0.00%)
After-Hours: 18:02
Alnylam Pharmaceuticals Price to Book Value: 519.41 for March 26, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pfizer Inc | 1.618 |
| Biomarin Pharmaceutical Inc | 2.411 |
| BridgeBio Pharma Inc | -- |
| Regeneron Pharmaceuticals Inc | 2.382 |
| Vertex Pharmaceuticals Inc | 7.830 |
Price to Book Value Related Metrics
| PS Ratio | 15.28 |
| Price | 269.17 |
| Earnings Yield | -0.81% |
| Market Cap | 34.85B |